C12Y 304/21093
Proprotein convertase 1
Official title: Proprotein convertase 1 (3.4.21.93)
C12Y304/21093 (Proprotein convertase 1) appears on 2 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 5
- Assignees
- 6
- Inventors
- 8
- Latest grant
- 16 Mar 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides16 Mar 2021US 10,947,539 B2Portage Pharmaceuticals Ltd.
- Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides28 May 2019US 10,301,629 B2Portage Pharmaceuticals Ltd.
- Methods of producing human analog insulins and derivatives thereof in a mammalian cell29 May 2025US 2025/0171517 A1Ice Bear Therapeutics SPC
- Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides17 Jun 2021US 2021/0180069 A1PPL (BVI) Limited
- Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides23 May 2019US 2019/0153450 A1Portage Pharmaceuticals Ltd.
- Assays for evaluating cell culture reagents21 Jun 2018US 2018/0171362 A1Biogen MA Inc.
- Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides19 May 2016US 2016/0136293 A1Portage Pharmaceuticals Ltd.
Most cited
By later US patents
- Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides6US 10,301,629 B2Portage Pharmaceuticals Ltd. · 2019
- Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides1US 10,947,539 B2Portage Pharmaceuticals Ltd. · 2021